The Netherlands government has confirmed it will continue to supply Bedrocan oil (cannabis-based medicine) for existing UK prescriptions until 1 July 2021, the Department of Health and Social Care (DHSC) has said.
A “concerning doubling” in maternal deaths due to sudden unexpected death in epilepsy (SUDEP) was seen between 2016-18 compared to 2013-15, a new report has shown.
Several epilepsy medicines carry risks when taken in pregnancy, a review, published today by the Medicines and Healthcare products Regulatory Agency (MHRA), has found.
After 19 years of service as the deputy chief executive of Epilepsy Action, Simon Wigglesworth will retire at the end of this year.
Social media platform TikTok is adding a new feature to protect people with photosensitive epilepsy from landing on content that could trigger a seizure.
New game Cyberpunk 2077, out today, contains flashing images which could trigger seizures in people with photosensitive epilepsy.
Epilepsy Action and Epilepsy Research UK are jointly funding a new research project comparing remote and face-to-face seizure clinic consultations.
New guidance to improve epilepsy treatment for people with learning disabilities was launched in November 2020.
The families of the campaign End Our Pain have written an open letter to the Prime Minister Boris Johnson to ask for his support with cannabis-based medicine prescriptions.
People with epilepsy should be included in the clinical risk group of people who should receive the COVID-19 vaccine early, according to provisional guidance from the government’s Green Book.
